News
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
8h
News-Medical.Net on MSNCity size reduces obesity and impulsivity through better lifestyle and educationResearchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less ...
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
Understanding the goals of your patients can help alleviate some pushback from the start of an appointment.
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down following a plunge in the company's share price ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...
Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.
Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to ...
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results